Literature DB >> 24338532

Autoimmune diseases, their pharmacological treatment and the cardiovascular system.

Marta Jastrzębska, Michael E Czok, Przemysław Guzik1.   

Abstract

Cardiovascular system involvement is a frequent complication of autoimmune diseases (AD) such as systemic lupus erythematosus, scleroderma, rheumatoid arthritis, spondyloarthropaties or psoriatic arthritis. The most common forms of such involvement are pericarditis, myocarditis, accelerated atherosclerosis resulting in myocardial infarction or stroke, arrhythmias, conduction abnormalities or congestive heart failure. Some of these manifestations may be dramatic in their course and ultimately fatal. The treatment of AD may further affect the cardiovascular system and result in a lower quality of life, higher mortality and increased cost of healthcare. The aim of this review is to discuss possible cardiac complications of various AD and the related treatment of these diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24338532     DOI: 10.5603/CJ.2013.0156

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  6 in total

1.  Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination.

Authors:  Samantha Lane; Alison Yeomans; Saad Shakir
Journal:  BMJ Open       Date:  2022-07-01       Impact factor: 3.006

2.  Systemic autoimmunity induced by the TLR7/8 agonist Resiquimod causes myocarditis and dilated cardiomyopathy in a new mouse model of autoimmune heart disease.

Authors:  Muneer G Hasham; Nicoleta Baxan; Daniel J Stuckey; Jane Branca; Bryant Perkins; Oliver Dent; Ted Duffy; Tolani S Hameed; Sarah E Stella; Mohammed Bellahcene; Michael D Schneider; Sian E Harding; Nadia Rosenthal; Susanne Sattler
Journal:  Dis Model Mech       Date:  2017-03-01       Impact factor: 5.758

Review 3.  Cardiac phenotype in mouse models of systemic autoimmunity.

Authors:  Chandan Sanghera; Lok Man Wong; Mona Panahi; Amalia Sintou; Muneer Hasham; Susanne Sattler
Journal:  Dis Model Mech       Date:  2019-03-08       Impact factor: 5.758

Review 4.  Focus on Autoimmune Myocarditis in Graves' Disease: A Case-Based Review.

Authors:  Lujin Wu; Wei Wang; Qianru Leng; Nana Tang; Ning Zhou; Yan Wang; Dao Wen Wang
Journal:  Front Cardiovasc Med       Date:  2021-07-07

Review 5.  The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC.

Authors:  Stefan Frantz; Ines Falcao-Pires; Jean-Luc Balligand; Johann Bauersachs; Dirk Brutsaert; Michele Ciccarelli; Dana Dawson; Leon J de Windt; Mauro Giacca; Nazha Hamdani; Denise Hilfiker-Kleiner; Emilio Hirsch; Adelino Leite-Moreira; Manuel Mayr; Thomas Thum; Carlo G Tocchetti; Jolanda van der Velden; Gilda Varricchi; Stephane Heymans
Journal:  Eur J Heart Fail       Date:  2018-01-15       Impact factor: 15.534

6.  Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition.

Authors:  Mona Panahi; Angelos Papanikolaou; Azam Torabi; Ji-Gang Zhang; Habib Khan; Ali Vazir; Muneer G Hasham; John G F Cleland; Nadia A Rosenthal; Sian E Harding; Susanne Sattler
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.